+ to H + and NH 3 , followed by the diffusion of NH 3 out of the cell. In standard buffered solution, the initial rate of pH i (ΔpH/Δt) recovery from the acid load (over the first 200 60 sec) reflects the activities of NHEs, whereas in HCO 3 -/CO 2 -buffered solutions represents 201 the activities of both NHEs and NBC.(18, 20) In order to estimate CBE activity the initial rate 202 of pH i recovery from alkalosis in HCO 3 -/CO 2 -buffered solutions was analyzed. Previous data 203 have indicated that under these conditions the recovery over the first 30 sec reflects the 204 activity of CBE. (18, 20) 205 In order to evaluate transmembrane base flux (J(B -)) the following equation was used: 206 J(B -)= ΔpH/Δt X β total , where ΔpH/Δt was calculated by linear regression analysis, whereas 207 the total buffering capacity (β total ) was estimated by the Henderson-Hasselbach equation using 208 the following formula: β total = β i + β HCO3-= β i + 2.3x i . We denote base influx as J(B) 209 and base efflux (secretion) as -J(B -). 210 211
Measurement of mitochondrial membrane potential 212
Mitochondrial membrane potential (ΔΨ m ) was measured using the lipophilic, 213 mitochondria-selective fluorescence dye, TMRM. Accumulation of TMRM in the 214 mitochondria depends on the ΔΨ m . Pancreatic ducts were pre-incubated with TMRM (1 µM) 215
for 30 min at 37 o C and transferred to a poly-l-lysine-coated cover slip (24 mm) forming the 216 base of a perfusion chamber. Ducts were then perfused continuously with solutions at 37 o C at 217 a rate of 2-2.5ml/min. The perfusion solutions were complemented with 100 nM TMRM to 218 avoid dye leakage. Changes in ΔΨ m were monitored using a Fluoview 10i-W confocal 219 microscope (Olympus, Budapest, Hungary). 5-10 ROIs (mitochondria) of 5-10 cells were 220 excited with light at 543 nm and the emitted light was captured between 560-650 nm. We 221 have employed the dequench method for the estimation of ΔΨ m . At the applied concentration 222 of TMRM, depolarisation of the mitochondria causes release of the dye and its dequenching 223 in the cytosol. Thus increase in fluorescence intensity reflects a decrease in ΔΨ m . 224
Fluorescence signals were normalised to initial fluorescence intensity (F/F 0 were then washed at 37 o C at the perfusion rate of 5-6 ml/min and imaged using an Olympus 237 IX71 fluorescence microscope (Olympus, Budapest, Hungary). 5-6 ROIs were excited with 238 light at 495 nm and the emitted light was captured at 515 nm. Fluorescence signals were 239 normalised to initial fluorescence intensity (F/F 0 ) and expressed as relative fluorescence. 240
241

TUNEL cell death assay 242
For detection of cell death we used the terminal deoxyribonucleotidyl transferase 243 (TDT)-mediated dUTP-digoxigenin nick end labelling (TUNEL) assay (Roche Diagnostics, 244
Mannheim, Germany). Intra-interlobular pancreatic ducts were treated with bile acids as 245 previously described. Control and bile acid-treated isolated duct segments were fixed with 4% 246 paraformaldehyde overnight and then cryosectioning and staining of the samples were 247 performed according to the manufacturer's protocol. The CDCA-treated groups were 248 incubated for 3 h in culture media before fixation. Pictures were taken with the use of a Zeiss 249
AxioImager fluorescent light microscope (Carl Zeiss MicroImaging, Thornwood, NY, USA) 250 fitted with a PixeLINK CCD camera (PixeLINK, Ottawa, ON, Canada) 251
252
Transmission electron microscopy 253
For electron microscopic studies, ducts were fixed in 2.5% glutaraldehyde 254 immediately after isolation. Samples were then postfixed in 1% osmium tetroxide, dehydrated 255 in a series of graded ethanols, and subsequently embedded in epoxy resin. Ultrathin sections 256 were contrasted with uranyl acetate and lead citrate. Tissue sections were analyzed under a 257 transmission electron microscope (CM10; Philips, Eindhoven, The Netherlands). 258
Induction of acute pancreatitis 259
Male Sprague Dawley (SPRD) rats weighing 200-250 g were used for all experiments. 260
Rats were kept at constant room temperature of 24°C with a 12 h light and dark cycle and 261 were allowed free access to tap water and standard laboratory chow (Biofarm, Zagyvaszaántó, 262 Hungary). Animal were fasted 12 h before the surgical procedure. All experiments were 263 approved by the Institutional Animal Care and Use Committee of the University of Szeged (I-264 74-3/2012 MÁB) and also by an independent committee assembled by national authorities 265 (XII./3773/2012.). Rats were randomly allocated into four groups (n=6) as follows: (1) 266 control (intraductal administration of physiological saline), (2) UDCA (rats were treated with 267 oral UDCA without induction of pancreatitis), (3) CDCA (pancreatitis was induced by 268 intraductal administration of CDCA) and (4) UDCA+CDCA (rats were treated with oral 269 UDCA and pancreatitis was induced with intraductal administration of CDCA). 270
Ursodeoxycholic acid (Ursofalk) was purchased from Dr Falk Pharma Ltd. UDCA was 271 dissolved in 2 mL of tap water and 250 mg/kg of body weight was administered orally 272 Rats were anesthetized with intraperitoneal injection of a cocktail containing of 50 277 mg/kg Ketamine and 10 mg/kg Xylazine. After the anesthesia, rats were shaved and the 278 abdominal cavity was opened with median laparotomy. The common bile duct was temporary 279 occluded with a vessel clip. The duodenum was punctured with a 0.4 mm diameter needle 280 13 connected to polyethylene tubing, then it was placed into the pancreatic duct and 1 ml/kg 1 % 281 sodium-CDCA (dissolved in physiologic saline) was administered via retrograde ductal 282 infusion with 1 ml/min speed with an infusion pump (TSE System GmbH, Bad Homburg, 283 Germany). Control animals received intraductal physiological saline instead of bile acid. After 284 bile acid or physiological saline infusion, the vessel clip and the polyethylene tube were 285 removed and the abdominal wall and skin were closed. Rats were sacrificed 24 h after the 286 surgical procedure. 287
288
Histologic examination and laboratory parameter measurements 289
Terminal anesthesia was performed with 50 mg/kg sodium pentobarbital. The 290 abdominal and thoracic cavities were opened with a median laparotomy and thoracotomy and 291 blood was collected with cardiac puncture. The pancreas was removed immediately after the 292 blood collection and it was trimmed from fat and lymphatic tissues on ice. Pancreata were 293 dissected and only parts of the head and body were used for histological analysis and for 294 laboratorial measurements. Sections from the pancreatic tail didn't show any signs of necrosis 295 or inflammation, therefore it was not used later. The pancreatic head and body were 296 longitudinally dissected and one part of pancreas was put into 6 % neutral formaldehyde 297 solution, however other part was immediately frozen in liquid nitrogen. In vivo experiments were evaluated by using ANOVA followed by Bonferroni or 315 To investigate the acid-base transporters of pancreatic ducts, we used the ammonium 334 pre-pulse technique. In the absence of HCO 3 -the initial recovery from the acid phase is due to 335 the activity of the Na + /H + exchanger (NHE) ( Fig. 2A ). In the presence of HCO 3 -the recovery 336 from alkalosis reflects the activity of the Cl -/HCO 3 -exchanger (CBE), whereas the recovery 337 from acidosis results from the activity of both NHE and Na + / HCO 3 -cotransporter (NBC) 338 (Fig. 2B ). Two NH 4 Cl pulses were applied, the first was the control and the second was the 339 test. To estimate the effect of bile acids on the activity of acid-base transporters CDCA (1 340 mM) and UDCA (0.1, 0.25, 0.5 and 1 mM) were administered 3 minutes before the pulse, 341 during the pulse and 5 minutes after the pulse. Acute administration of UDCA did not affect 342 the rate of recovery from the acid or alkali load neither in Hepes-buffered nor in HCO 3 -/CO 2 -343 buffered solutions (data not shown). In contrast, 1 mM CDCA strongly inhibited the activity 344 of the acid/base transporters. ( Fig. 2A and ] i (data 367 not shown). In contrast, 1 mM CDCA induced high and partially reversible Ca 2+ signalling in 368 pancreatic ducts. (Fig. 3A ) Pre-incubation of the ducts with 0.5 mM UDCA for 24 h did not 369 affect the CDCA-induced increase in [Ca 2+ ] i , (Fig. 3A and B The level of ATP i is a good indicator of mitochondrial function; therefore in the first 381 step we measured changes in ATP i in cells exposed to CDCA with or without UDCA pre-382 treatment. As shown on Fig. 3C , administration of 1 mM CDCA caused a huge and 383 irreversible ATP i loss in PDECs. (Fig. 3C ) In contrast, 24 h preincubation of the cells with 0.5 384 mM UDCA reduced the rate of CDCA-induced ATP i decrease by 57.6±3.6 % ( Fig. 3C and 385 D). UDCA administration alone did not effect ATP i . 386
To further analyse the protective effect of UDCA on ductal mitochondria, we also 387 investigated ΔΨ m and mPTP upon administration of bile acids. Ducts were incubated with 1 388 μM TMRM in order to investigate the changes in ΔΨ m (see Material and Methods section). 389
After the stabilisation of the mitochondrial fluorescence, 1 mM CDCA was applied and the 390 fluorescence signal was monitored. As shown in Fig. 3E , the administration of CDCA 391 resulted in a huge increase in TMRM fluorescence intensity, indicating that this bile acid 392 18 induced marked mitochondrial depolarization. Preincubation of the ducts with 0.5 mM UDCA 393 reduced the CDCA-induced depolarization by 69.4±4.6% ( Fig. 3E and F) . 394
Since ATP depletion and mitochondrial depolarization are caused by mPTP induction, 395 next we investigated the effect of CDCA on the opening of mPTP using the calcein-cobalt 396 technique. Treatment of the calcein-loaded pancreatic ducts with 1 mM CDCA decreased the 397 fluorescence excitation of calcein, approximately 1 min after the addition of the bile acid. 398 (Fig. 3G) Similarly to the ΔΨ m experiments, 24 h pretreatment of the ducts with 0.5 mM 399
UDCA had a preventive role on mitochondria and decreased the CDCA-induced mPTP 400 opening by 72.1±4%. (Fig. 3G and H) Administration of UDCA alone did not affect mPTP. 401
We also examined the morphology of the ductal mitochondria using electron 402 microscopy ( Fig. 4A-D) . The mean number of mitochondria in the section of the control, the 403 CDCA, the UDCA and the CDCA+UDCA groups was nearly the same. No morphological 404 alterations were observed in the control and UDCA-treated groups. (Fig. 4A and B) In 405 contrast, incubation of the ducts with 1 mM CDCA for 5 min resulted in mitochondrial 406 swelling and the loss of the mitochondrial inner membrane (Fig. 4C) . This swelling could be 407 prevented by UDCA pre-treatment. Moreover, the integrity of the mitochondria was also 408 maintained in the CDCA+UDCA-treated ducts compared to the ducts only treated with 409 CDCA (Fig. 4D) . 410 411 UDCA pre-treatment prevented the CDCA-induced cell death 412
In the next step, we tested whether the toxic effect of CDCA on the mitochondria is 413 associated with cell death. Ducts were treated with 1 mM CDCA for 5 min, then were 414 incubated in culture media for further 3 h in order to leave time for development of cell death. 415
Cell death was assessed by TUNEL staining (Fig. 5A and B) . This method is based on the 416 labelling of the 3'-OH ends of the fragmented DNA which are generated during cell death. 417
Incubation of the pancreatic ducts with CDCA resulted in a significant increase in cell death 418 compared to control, non-treated ducts. (Fig. 5A and B ) Although, both apoptosis and 419 necrosis can be characterised by DNA fragmentation,(17) the presence of intact cell 420 organelles, cellular shrinkage and the lack of cellular content release indicate that CDCA 421 rather induces apoptotic cell death than necrosis. 24 h preincubation with UDCA (0.5 mM) 422 alone caused only a small degree of DNA fragmentation in the ductal cells, but significantly 423 reduced the CDCA-induced apoptotic cell death by 63.3±5.7 %. (Fig. 5A and B Serum amylase activities were significantly elevated after retrograde infusion of 431 CDCA (CDCA group, 983±100 U/l) compared to intraductally administered physiological 432 saline (control group, 396±50 U/l). Pretreatment of UDCA for two weeks did not influence 433 the serum amylase activities (UDCA group, 424.7 ± 20) in control animals; however, it was 434 significantly decreased (582 ± 50 U/l) in the UDCA+CDCA group versus the CDCA group. 435 (Fig. 6A ) 436
Pancreatic water content was significantly elevated after retrograde infusion of CDCA 437 (80±1%) compared to intraductally administered physiological saline (60±1%). A two-week 438 pretreatment with UDCA showed no influence on the pancreatic water content (61±2%) in the 439 UDCA group. However in the UDCA+CDCA group, it was significantly decreased (65±2%) 440 versus to the CDCA group. (Fig. 6B ) 441 20 Pancreatic damage was characterized by determining the extent of tissue necrosis (Fig.  442 6C-D). Intraductal infusion of physiological saline with or without UDCA pretreatment didn't 443 cause any acinar cell necrosis. However, retrograde infusion of CDCA caused markedly 444 elevated (14±2%) acinar cell damage, which was significantly ameliorated (6±2%) in the 445 UDCA+CDCA group. (Fig. 6C) UDCA is able to attenuate the toxic effect of CDCA on pancreatic ducts by preventing 472
CDCA-induced mitochondrial injury. 473
We used isolated intra-interlobular pancreatic ducts, which is a reliable in vitro model 474 for investigating pancreatic ductal damage. The CDCA concentration used in this study was 475 previously shown to induce intracellular Ca 2+ signalling, mitochondrial injury and inhibition 476 of the acid-base transporters,(29, 59) whereas the concentrations of UDCA were chosen on 477 the basis of the literature data. (42, 43) Examinations were performed using 0.5 mM UDCA 478 since the protective effect of UDCA was not increased by using higher concentrations (1 479 mM), whereas lower concentrations of this bile acid (0.1 and 0.25 mM) had no detectable 480 protective effect. This concentration of UDCA is one magnitude higher than the physiological 481 concentration of bile acid in the blood (9) and several orders of magnitude lower than the 482 concentration of bile acids in the gall bladder or duodenum (10-100 mM). The optimal pre-483 incubation time of pancreatic ducts with UDCA was found to be 24 h, indicating that the 484 development of protective action is a complex mechanism which probably include changes at 485 transcriptional level that modulate various signalling and apoptotic pathways. acid/base transporters is due to the prevention of CDCA-induced calcium signalling. When 493 pancreatic ducts were exposed to UDCA for 24 h and CDCA was then added, the extent of 494 calcium elevation did not change, indicating that the protective effect of UDCA is unlikely to 495 be caused by the reduction of Ca 2+ signalling. This finding is in accordance with our previous 496 observation on pancreatic ducts, where pre-incubation of the cells with a specific calcium 497 chelator, BAPTA-AM was unable to prevent the inhibitory effect of CDCA on acid-base 498 transporters. (59) 499 An increasing number of studies support the concept that mitochondrial damage plays 500 a central role in the bile-induced cellular injury and that UDCA pretreatment is able to 501 attenuate the toxic effect of hydrophobic bile acids on mitochondria.(8, 41-43) Therefore, in 502 the next step we investigated the protective effect of UDCA on the function and morphology 503 of pancreatic ductal mitochondria. Administration of CDCA alone induced mPTP opening in 504 the ductal cells. This is an early event in cell death which leads to mitochondrial swelling due 505 to an increase in the mitochondrial inner membrane permeability. mPTP is also characterized 506 by the loss of membrane potential which leads to mitochondrial dysfunction and consequently 507 inhibition of ATP synthesis. We did not investigate the exact mechanism by which CDCA 508 induces mPTP opening. Studies on rat hepatocytes demonstrated that in the presence of the 509 specific mPTP inhibitor, cyclosporine A, the effect of CDCA was completely ameliorated 510 indicating that CDCA selectively acts on mPTP. (45) It has been also demonstrated that 511 CDCA induces mPTP due to increased membrane fluidity and cytochrome c release in 512 calcium-loaded hepatic mitochondria. (44) In contrast to the effects of CDCA, UDCA alone 513 caused no significant changes in mitochondrial function. However, in combination with 514 CDCA, UDCA was able to prevent the CDCA-induced mPTP, mitochondrial membrane 515 perturbation and the consequently formed decrease in membrane potential. Moreover, UDCA 516 23 prevented the CDCA-induced ATP i loss, which provides further evidence that UDCA 517 pretreatment is beneficial to avoid mitochondrial injury. This conclusion was confirmed by 518 electron microscopic studies which showed normal appearance of mitochondria in the 519 UDCA+CDCA group compared to the CDCA group, where mitochondrial swelling and 520 disruption of the inner mitochondrial membrane were observed. The mechanism underlying 521 the mitochondrial protective effect of UDCA is not clear. One of the main inducers of mPTP 522 is Ca 2+ overload and oxidative stress. Although, we have shown that UDCA pre-treatment had 523 no effect on the extent of CDCA-induced Ca 2+ elevation, we did not investigate the effect of 524 UDCA on the total Ca 2+ load. It is possible that the protective effect of UDCA is due to the 525 reduction of Ca 2+ overload or by the inhibition of reactive oxygen species (ROS) production, 526 however further studies are needed to confirm these hypotheses. 527
Mitochondrial dysfunction is often associated with cell death either by the reduction of 528 confirms the cytoprotective effect of UDCA. The exact mechanism by which UDCA exerts its 543 protective effect was not investigated by our group; however, our results and previous studies 544 on hepatocytes strongly indicate that mPTP inhibition by UDCA is one of the key 545 mechanisms in the reduction of CDCA-induced cell death in PDECs. 546
In order to extend our study, we also tested the protective effect of UDCA in vivo. 547
There is no accepted pancreatitis model in guinea pigs; therefore we induced AP in rats by 548 intraductal injection of low concentration of CDCA.(53, 54) Under these experimental 549 conditions, CDCA induced acinar cell damage and also increased serum amylase activity. 550
Previous studies on isolated rat and mouse acini demonstrated that the hydrophobic bile acid, 551 TLC-S induces mitochondrial injury, pathological Ca 2+ signalling and the generation of 552 ROS. (7, (61) (62) (63) We speculate that similar intracellular mechanisms may also have arisen in 553 response to CDCA. The CDCA-induced acinar cell injury, hyperamylasemia and pancreatic 554 edema were markedly reduced in the UDCA-treated group. The protective effect of UDCA 555 can be attributed to its ability to reduce mitochondrial injury both in acinar and ductal cells. 556
Several attempts have been made in order to investigate the effect of UDCA on isolated 557 pancreatic acinar cells. Using rat and mouse acinar cells, we found that isolated acinar cells 558 are more sensitive to long term bile acid treatment than ductal cells, which made the 559 investigation of the protective effect of UDCA very difficult. Cell viability experiments 560
showed that even at low concentrations, bile acids decreased the viability of isolated acinar 561 cells and in contrast to ductal cells, UDCA pre-treatment had no protective effect on acinar 562 cells under our experimental conditions (data not shown). orally administered UDCA is highly dependent on its metabolism. In rats, most of the UDCA 569 is metabolized to TUDCA (40) which also has cytoprotective effect as demonstrated in the 570 liver. (4, 5, 37, 50) In humans, one of the major metabolites of UDCA is isoursodeoxycholic 571 acid (isoUDCA) (6) which is the 3β-hydroxy epimer of UDCA and has been shown to be 572 more effective than UDCA.(30) In the current study, we have not investigated the serum 573 concentration of UDCA after oral administration. Notably, since UDCA was administered in 574 an excess dose, we believe that sufficiently high concentration of UDCA (or TUDCA) was 575 present in the serum to exert its protective effect. 576
Understanding the early injury mechanisms induced by hydrophobic bile acids is 577 extremely important to find a therapeutic target to reduce pancreatic injury. In this study, we 578 confirm and extend our previous observations that mitochondria is a key target in the CDCA-579 induced cellular injury in PDECs. The hydrophilic bile acid, UDCA inhibits CDCA-induced 580 apoptosis probably by the stabilization of mitochondrial membrane via the block of 581 membrane depolarization and mPTP and also by prevention of mitochondrial swelling (Fig.  582   7) . Several studies have focused on the inhibition of cellular injury during AP in order to stop 583 or delay the progression of the disease. UDCA may represent a novel option against the bile-584 induced ductal injury, however issues for the therapeutic application of this bile acid in AP 585 need further investigation. 
